Skip to main content
Livermore
Livermore
ZHEN

D. E. Shaw & Co., Inc.

SEC CIK
0001009207
Latest filing
Aug 14, 2026

BIO holding history

Bio-Rad Laboratories, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

BIO overviewAll 13F holders of BIOFull Q2 2026 holdings

Shares (Q2 2026)
19,256
Value
$5.65M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of BIO by D. E. Shaw & Co., Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202619,256$5.65M<0.1%+11,111+136.4%AddedHolders
Q1 20268,145$2.27M<0.1%+3,315+68.6%AddedHolders
Q4 20254,830$1.46M<0.1%+1,530+46.4%AddedHolders
Q3 20253,300$925.3K<0.1%00.0%UnchangedHolders
Q2 20253,300$796.4K<0.1%−15,625−82.6%ReducedHolders
Q1 202518,925$4.61M<0.1%−5,700−23.1%ReducedHolders
Q4 202424,625$8.09M<0.1%+7,837+46.7%AddedHolders
Q3 202416,788$5.62M<0.1%−26,188−60.9%ReducedHolders
Q2 202442,976$11.7M<0.1%−3,649−7.8%ReducedHolders
Q1 202446,625$16.1M<0.1%−12,729−21.4%ReducedHolders
Q4 202359,354$19.2M<0.1%+47,242+390.0%AddedHolders
Q3 202312,112$4.34M<0.1%+809+7.2%AddedHolders
Q2 202311,303$4.29M<0.1%−3,898−25.6%ReducedHolders
Q1 202315,201$7.28M<0.1%−33,557−68.8%ReducedHolders
Q4 202248,758$20.5M<0.1%+33,437+218.2%AddedHolders
Q3 202215,321$6.39M<0.1%−2,897−15.9%ReducedHolders
Q2 202218,218$9.02M<0.1%−9,718−34.8%ReducedHolders
Q1 202227,936$15.7M<0.1%+17,807+175.8%AddedHolders
Q4 202110,129$7.65M<0.1%+3,191+46.0%AddedHolders
Q3 20216,938$5.17M<0.1%−6,246−47.4%ReducedHolders
Q2 202113,184$8.49M<0.1%+7,392+127.6%AddedHolders
Q1 20215,792$3.31M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.